We also conducted a review of published PNS cases in patients presenting with parkinsonism; we focused on those cases with positivity for anti-GAD65 and anti-CRMP5 onconeural antibodies. The gene discussed is GAD2; the disease is paraneoplastic neurologic syndrome.